Details & documentation Available as a research material
Expert Opin Investig Drugs 32(5):355359 Urva S, Coskun T, Loh MT, Du Y, Thomas MK, Gurbuz S et al (2022) LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
GLP1/2 fusion Fc proteins have been shown to lower weight, alleviate fibrosis, improve tight junctions, and increase microvillus height (Kim et al., 2022)
This helps to regulate blood sugar levels in the body
2025 Sep 17;393(11):107787
Pero la promesa de conseguir adelgazar sin esfuerzo, con un pinchazo a la semana, no solo interesa a personas con problemas de salud